- 2024.09.30
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Unavailable Manufacturing 27/09/2024 salbutamol sulfate Inhalation, conventional 3 mg Current Unavailable Manufacturing 27/09/2024 framycetin sulfate~dexamethasone~gramicidin Ear Drops 5 mg/mL~.5 mg/mL~.05 mg/mL Current Limited Availability Manufacturing 27/09/2024 octreotide Injection, solution 100 microgram Current Limited Availability Manufacturing 27/09/2024 octreotide Injection, solution 500 microgram Current Unavailable Manufacturing 27/09/2024 octreotide Injection, solution 50 microgram Current Unavailable Manufacturing 27/09/2024 buprenorphine hydrochloride Injection, solution 324 microgram/mL Current Unavailable Manufacturing 27/09/2024 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 27/09/2024 mycophenolate mofetil Tablet, film coated 500 mg Current Limited Availability Manufacturing 27/09/2024 metronidazole Tablet, uncoated 400 mg Resolved Available Manufacturing 27/09/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Limited Availability Manufacturing 27/09/2024 tranexamic acid Injection, solution 1000 mg Anticipated Available Commercial Changes / Commercial viability 27/09/2024 fenofibrate Tablet 48 mg Current Limited Availability Manufacturing 27/09/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Current Unavailable Manufacturing 27/09/2024 tadalafil Tablet 5 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 27/09/2024 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Current Unavailable Manufacturing 27/09/2024 phenytoin sodium Capsule, hard 100 mg Current Limited Availability Manufacturing 27/09/2024 gliclazide Tablet, modified release 30 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 27/09/2024 modafinil Tablet, uncoated 100 mg Current Limited Availability Manufacturing 27/09/2024 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 27/09/2024 chloramphenicol Eye Drops, solution 5 mg/mL Current Unavailable Manufacturing 27/09/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Anticipated Available Manufacturing 27/09/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Anticipated Available Manufacturing 27/09/2024 paracetamol Tablet, modified release 665 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 27/09/2024 clonazepam Tablet, uncoated 2 mg Current Limited Availability Manufacturing 27/09/2024 tobramycin Inhalation, conventional 60 mg/mL Current Unavailable Manufacturing 27/09/2024 morphine sulfate pentahydrate Capsule, modified release 120 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 27/09/2024 morphine sulfate pentahydrate Capsule, modified release 90 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 27/09/2024 morphine sulfate pentahydrate Capsule, modified release 60 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 27/09/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Resolved Available Manufacturing 27/09/2024 primidone Tablet, uncoated 250 mg Current Limited Availability Manufacturing 26/09/2024 ramipril Capsule, hard 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/09/2024 propofol Injection, emulsion 500 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/09/2024 oxytocin Injection, solution 10 IU Anticipated Available Manufacturing 26/09/2024 temozolomide Capsule, hard 100 mg Resolved Available Transport / Logistic issues / Storage capacity issues 26/09/2024 lurasidone hydrochloride Tablet, film coated 40 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/09/2024 lurasidone hydrochloride Tablet, film coated 80 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/09/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, multilayer 10.9 mg~10 mg Current Unavailable Manufacturing 26/09/2024 epirubicin hydrochloride Injection, concentrated 200 mg Current Unavailable Manufacturing 26/09/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 26/09/2024 tadalafil Tablet, film coated 20 mg Current Unavailable Unexpected increase in consumer demand 26/09/2024 lidocaine hydrochloride Injection, solution 400 mg Current Unavailable Manufacturing 26/09/2024 nebivolol hydrochloride Tablet 10.9 mg Current Limited Availability Manufacturing 26/09/2024 montelukast sodium Tablet, film coated 10.4 mg Current Unavailable Manufacturing 26/09/2024 bortezomib Injection, solution 3.5 mg Current Unavailable Manufacturing 26/09/2024 bisoprolol fumarate Tablet, film coated 2.5 mg Discontinued Unavailable Commercial Changes / Commercial viability 26/09/2024 bisoprolol fumarate Tablet, film coated 5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/09/2024 bisoprolol fumarate Tablet, film coated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/09/2024 pamidronate disodium Injection, concentrated 3 mg Current Unavailable Manufacturing 26/09/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 25/09/2024 Rabies virus Injection, powder for 2.5 IU Current Emergency Supply Only Manufacturing 25/09/2024 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Anticipated Available Manufacturing 25/09/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 25/09/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 25/09/2024 gefitinib Tablet, film coated 250 mg Current Unavailable Manufacturing 25/09/2024 lurasidone hydrochloride Tablet, film coated 40 mg Resolved Available Manufacturing 25/09/2024 Rabies virus Powder 3.25 IU Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 25/09/2024 Adalimumab Injection, solution 40 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 25/09/2024 propranolol hydrochloride Tablet, film coated 40 mg Resolved Available Manufacturing 24/09/2024 adrenaline (epinephrine) Injection, solution 1 mg Current Limited Availability Manufacturing 24/09/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 24/09/2024 midazolam Injection, solution 5 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/09/2024 midazolam Injection, solution 1 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/09/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Unavailable Manufacturing 24/09/2024 buprenorphine Drug delivery system, transdermal 40 mg Resolved Available Transport / Logistic issues / Storage capacity issues 24/09/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 24/09/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 24/09/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/09/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Manufacturing 24/09/2024 ezetimibe Tablet 10 mg Current Unavailable Unexpected increase in consumer demand 24/09/2024 ezetimibe Tablet 10 mg Current Unavailable Unexpected increase in consumer demand 24/09/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Resolved Available Manufacturing 24/09/2024 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/09/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 24/09/2024 heparin sodium Injection, solution 10 IU/mL Current Limited Availability Manufacturing 24/09/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 2.7 mg~.62 mg Current Unavailable Manufacturing 24/09/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg Current Limited Availability Manufacturing 24/09/2024 ezetimibe Tablet 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 24/09/2024 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 23/09/2024 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 23/09/2024 olanzapine pamoate monohydrate Injection, powder for 483 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 23/09/2024 esomeprazole magnesium dihydrate Tablet, enteric coated 21.75 mg Resolved Available Manufacturing 23/09/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 23/09/2024 milrinone Injection, concentrated 10 mg Current Limited Availability Manufacturing 23/09/2024 hydromorphone hydrochloride Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/09/2024 hydromorphone hydrochloride Injection, solution 10 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/09/2024 hydromorphone hydrochloride Injection, concentrated 50 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/09/2024 levothyroxine sodium Tablet, uncoated .05 mg Anticipated Available Manufacturing 23/09/2024 levothyroxine sodium Tablet, uncoated .075 mg Anticipated Available Manufacturing 23/09/2024 erythromycin ethyl succinate Oral Liquid, powder for 468 mg Current Limited Availability Unexpected increase in consumer demand 23/09/2024 desmopressin acetate Spray, solution .1 mg/mL Current Unavailable Product recall 23/09/2024 rizatriptan benzoate Wafer 14.53 mg Current Limited Availability Manufacturing 23/09/2024 midazolam Injection, solution 1 mg/mL Current Limited Availability Manufacturing 23/09/2024 oxycodone hydrochloride Capsule, hard 5 mg Anticipated Available Manufacturing 23/09/2024 nizatidine Capsule 150 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/09/2024 nizatidine Capsule 300 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/09/2024 - 2024.09.24
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Anticipated Available Transport / Logistic issues / Storage capacity issues 22/09/2024 gabapentin Capsule, hard 300 mg Current Limited Availability Manufacturing 20/09/2024 sumatriptan succinate Tablet, film coated 140 mg Current Limited Availability Manufacturing 20/09/2024 venlafaxine Capsule, modified release 75 mg Current Limited Availability Manufacturing 20/09/2024 venlafaxine Capsule, modified release 150 mg Current Limited Availability Manufacturing 20/09/2024 Filgrastim Injection, solution 120 microgram Resolved Available Transport / Logistic issues / Storage capacity issues 20/09/2024 Filgrastim Injection, solution 480 microgram Resolved Available Transport / Logistic issues / Storage capacity issues 20/09/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 20/09/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 20/09/2024 fenofibrate Tablet 48 mg Anticipated Available Manufacturing 20/09/2024 buprenorphine Drug delivery system, transdermal 40 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 20/09/2024 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Current Unavailable Manufacturing 20/09/2024 trimethoprim Tablet, uncoated 300 mg Anticipated Available Manufacturing 20/09/2024 lenalidomide Capsule, hard 5 mg Current Limited Availability Unexpected increase in consumer demand 20/09/2024 lanreotide acetate Injection, solution 133.33 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 20/09/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 41.6 mg~10 mg Current Limited Availability Manufacturing 20/09/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 20.8 mg~10 mg Current Unavailable Manufacturing 20/09/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Current Limited Availability Unexpected increase in consumer demand 20/09/2024 clindamycin phosphate Lotion 10 mg/mL Current Limited Availability Manufacturing 20/09/2024 Epoetin lambda Injection, solution 10000 IU Resolved Available Manufacturing 19/09/2024 omeprazole Capsule 20 mg Resolved Available Manufacturing 19/09/2024 insulin Injection, solution 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/09/2024 insulin Injection, suspension 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/09/2024 insulin Injection, suspension 100 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/09/2024 Insulin detemir Injection, solution 100 U/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/09/2024 Insulin detemir Injection, solution 100 U/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/09/2024 bisoprolol fumarate Tablet 10 mg Anticipated Available Manufacturing 19/09/2024 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 19/09/2024 quetiapine fumarate Tablet, film coated 28.784 mg Resolved Available Unexpected increase in consumer demand 19/09/2024 paclitaxel Injection, concentrated 300 mg Current Unavailable Manufacturing 19/09/2024 cisatracurium besilate Injection, solution 201 mg Discontinued Unavailable Manufacturing 19/09/2024 Follitropin alfa Injection, solution 75 IU Anticipated Available Manufacturing 19/09/2024 Follitropin alfa Injection, solution 150 IU Anticipated Available Manufacturing 19/09/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Current Unavailable Manufacturing 19/09/2024 Insulin aspart Injection, solution 100 U/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/09/2024 Insulin aspart Injection, solution 100 U/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/09/2024 Insulin degludec~Insulin aspart Injection, solution 420 nmol/mL~180 nmol/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 19/09/2024 gliclazide Tablet, modified release 30 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/09/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 82.725 mg~10 mg Current Unavailable Manufacturing 19/09/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 41.363 mg~10 mg Current Unavailable Manufacturing 19/09/2024 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 19/09/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.94 mg Current Limited Availability Unexpected increase in consumer demand 19/09/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Unavailable Manufacturing 19/09/2024 levothyroxine sodium Tablet, uncoated .1 mg Current Unavailable Manufacturing 19/09/2024 levothyroxine sodium Tablet, uncoated .2 mg Current Limited Availability Manufacturing 19/09/2024 Dornase alfa Spray, solution 1 mg/mL Resolved Available Commercial Changes / Commercial viability 19/09/2024 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Anticipated Available Manufacturing 19/09/2024 captopril Tablet, uncoated 50 mg Current Unavailable Manufacturing 19/09/2024 clindamycin hydrochloride Solution 10 mg/mL Current Unavailable Manufacturing 19/09/2024 amoxicillin sodium Injection, powder for 1060 mg Current Limited Availability Manufacturing 19/09/2024 amoxicillin trihydrate Oral Liquid, powder for 114.82 mg/mL Current Unavailable Manufacturing 19/09/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Anticipated Available Manufacturing 18/09/2024 carmustine Injection, powder for 100 mg Resolved Available Manufacturing 18/09/2024 dulaglutide Injection, solution 1.5 mg Current Limited Availability Manufacturing 18/09/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.819 mg Resolved Available Manufacturing 18/09/2024 spironolactone Tablet, uncoated 100 mg Current Limited Availability Manufacturing 18/09/2024 chloramphenicol Eye Drops, solution 5 mg/mL Current Unavailable Manufacturing 18/09/2024 sitagliptin fumarate Tablet, film coated 128.497 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 18/09/2024 indometacin Capsule, hard 25 mg Current Unavailable Manufacturing 18/09/2024 captopril Tablet, uncoated 25 mg Current Unavailable Manufacturing 18/09/2024 estradiol~norethisterone acetate Drug delivery system, transdermal .62 mg~2.7 mg Current Unavailable Manufacturing 18/09/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Anticipated Available Manufacturing 18/09/2024 norethisterone Tablet, uncoated 350 microgram Current Unavailable Manufacturing 17/09/2024 isosorbide dinitrate Tablet, uncoated 5 mg Anticipated Available Manufacturing 17/09/2024 codeine phosphate hemihydrate~ibuprofen Tablet, film coated 12.8 mg~200 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 17/09/2024 simvastatin Tablet, film coated 20 mg Anticipated Available Manufacturing 17/09/2024 tenofovir disoproxil maleate~emtricitabine Tablet, film coated 300 mg~200 mg Current Unavailable Manufacturing 17/09/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 10.341 mg~10 mg Anticipated Available Manufacturing 17/09/2024 zolpidem tartrate Tablet, film coated 10 mg Anticipated Available Manufacturing 16/09/2024 medronic acid Injection, powder for 10 mg Anticipated Available Manufacturing 16/09/2024 gabapentin Tablet, film coated 600 mg Resolved Available Manufacturing 16/09/2024 adrenaline (epinephrine) Injection, solution 1 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/09/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 16/09/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/09/2024 oseltamivir phosphate Oral Liquid, powder for 7.88 mg/mL Resolved Available Unexpected increase in consumer demand 16/09/2024 azithromycin dihydrate Tablet, film coated 524.05 mg Current Unavailable Manufacturing 16/09/2024 quetiapine fumarate Tablet, film coated 345.36 mg Current Limited Availability Manufacturing 16/09/2024 irbesartan Tablet, film coated 300 mg Anticipated Available Manufacturing 16/09/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Unavailable Manufacturing 16/09/2024 olmesartan medoxomil Tablet, film coated 40 mg Anticipated Available Manufacturing 16/09/2024 olmesartan medoxomil~hydrochlorothiazide Tablet, film coated 40 mg~25 mg Anticipated Available Manufacturing 16/09/2024 azacitidine Injection, powder for 100 mg Current Limited Availability Manufacturing 16/09/2024 anastrozole Tablet, film coated 1 mg Anticipated Available Manufacturing 16/09/2024 irbesartan Tablet, film coated 150 mg Current Unavailable Manufacturing 16/09/2024 tadalafil Tablet 5 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 16/09/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 16/09/2024 nebivolol hydrochloride Tablet 5.45 mg Anticipated Available Manufacturing 16/09/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 16/09/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 16/09/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 16/09/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 16/09/2024 amlodipine besilate~olmesartan medoxomil Tablet, film coated 6.935 mg~40 mg Current Unavailable Manufacturing 16/09/2024 lacosamide Tablet, film coated 150 mg Anticipated Available Manufacturing 16/09/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~10.341 mg Current Unavailable Manufacturing 16/09/2024 lenalidomide Capsule 5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/09/2024 lenalidomide Capsule 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/09/2024 lenalidomide Capsule 15 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/09/2024 lenalidomide Capsule 25 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 16/09/2024 gefitinib Tablet, film coated 250 mg Current Unavailable Manufacturing 16/09/2024 methotrexate Tablet 10 mg Anticipated Available Manufacturing 16/09/2024 heparin sodium Injection, solution 1000 IU/mL Current Unavailable Manufacturing 16/09/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Current Unavailable Manufacturing 16/09/2024 - 2024.09.17
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated siponimod hemifumarate Tablet, film coated .278 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/09/2024 adrenaline (epinephrine) Injection, solution 1 mg Current Limited Availability Manufacturing 13/09/2024 isoniazid Tablet, uncoated 100 mg Current Unavailable Manufacturing 13/09/2024 pentetic acid Injection, powder for 5 mg Anticipated Available Manufacturing 13/09/2024 sodium pyrophosphate Injection, powder for 30 mg Anticipated Available Manufacturing 13/09/2024 Pancreatic extract Capsule, enteric 150 mg Current Limited Availability Unexpected increase in consumer demand 13/09/2024 methotrexate Injection, solution 100 mg/mL Anticipated Available Manufacturing 13/09/2024 acetylcysteine Injection, concentrated 2 g Anticipated Available Transport / Logistic issues / Storage capacity issues 13/09/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.791 mg Current Limited Availability Manufacturing 13/09/2024 quetiapine fumarate Tablet, film coated 28.784 mg Current Limited Availability Unexpected increase in consumer demand 13/09/2024 simvastatin Tablet, film coated 40 mg Anticipated Available Manufacturing 13/09/2024 acarbose Tablet 50 mg Current Unavailable Manufacturing 13/09/2024 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Anticipated Available Manufacturing 13/09/2024 lurasidone hydrochloride Tablet, film coated 80 mg Anticipated Available Manufacturing 13/09/2024 mycophenolate mofetil Injection, powder for 500 mg Resolved Available Manufacturing 13/09/2024 oseltamivir phosphate Capsule, hard 98.524 mg Anticipated Available Unexpected increase in consumer demand 13/09/2024 flucloxacillin sodium monohydrate Injection, powder for 1088.1 mg Resolved Available Transport / Logistic issues / Storage capacity issues 13/09/2024 methylphenidate hydrochloride Tablet, modified release 27 mg Anticipated Available Manufacturing 13/09/2024 phenytoin sodium Injection, solution 100 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 13/09/2024 rifabutin Capsule, hard 150 mg Anticipated Available Manufacturing 13/09/2024 amoxicillin trihydrate Oral Liquid, powder for 114.82 mg/mL Current Unavailable Manufacturing 13/09/2024 clarithromycin Tablet, film coated 250 mg Anticipated Available Unexpected increase in consumer demand 13/09/2024 primidone Tablet, uncoated 250 mg Current Limited Availability Manufacturing 12/09/2024 topiramate Tablet, film coated 200 mg Anticipated Available Manufacturing 12/09/2024 morphine hydrochloride trihydrate Oral Liquid, solution 2 mg/mL Current Unavailable Commercial Changes / Commercial viability 12/09/2024 morphine hydrochloride trihydrate Oral Liquid, solution 5 mg/mL Current Unavailable Commercial Changes / Commercial viability 12/09/2024 morphine hydrochloride trihydrate Oral Liquid, solution 10 mg/mL Current Unavailable Commercial Changes / Commercial viability 12/09/2024 olanzapine Tablet, orally disintegrating 20 mg Anticipated Available Manufacturing 12/09/2024 mycophenolate mofetil Tablet, film coated 500 mg Current Limited Availability Manufacturing 12/09/2024 omeprazole Capsule 20 mg Current Limited Availability Manufacturing 12/09/2024 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 12/09/2024 simvastatin Tablet, film coated 10 mg Anticipated Available Manufacturing 12/09/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 12/09/2024 atorvastatin calcium trihydrate Tablet, film coated 86.76 mg Current Limited Availability Manufacturing 12/09/2024 nebivolol hydrochloride Tablet 1.363 mg Anticipated Available Manufacturing 12/09/2024 acamprosate calcium Tablet, enteric coated 333 mg Anticipated Available Manufacturing 12/09/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~41.363 mg Current Unavailable Manufacturing 12/09/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 20.681 mg~10 mg Current Unavailable Manufacturing 12/09/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~82.725 mg Current Unavailable Manufacturing 12/09/2024 lanreotide acetate Injection, solution 133.33 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 12/09/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 12/09/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Manufacturing 12/09/2024 tobramycin Inhalation, conventional 60 mg/mL Current Unavailable Manufacturing 12/09/2024 amoxicillin sodium Injection, powder for 1060 mg Anticipated Available Manufacturing 12/09/2024 metoprolol succinate Tablet, modified release 47.5 mg Anticipated Available Manufacturing 11/09/2024 metoprolol succinate Tablet, modified release 190 mg Anticipated Available Manufacturing 11/09/2024 metoprolol succinate Tablet, modified release 95 mg Anticipated Available Manufacturing 11/09/2024 bisoprolol fumarate Tablet 2.5 mg Current Unavailable Manufacturing 11/09/2024 bisoprolol fumarate Tablet 5 mg Current Unavailable Manufacturing 11/09/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Unavailable Manufacturing 11/09/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Unavailable Manufacturing 11/09/2024 citalopram hydrobromide Tablet, film coated 12.495 mg Anticipated Available Manufacturing 11/09/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 11/09/2024 ezetimibe Tablet 10 mg Current Unavailable Unexpected increase in consumer demand 11/09/2024 ezetimibe Tablet 10 mg Current Unavailable Unexpected increase in consumer demand 11/09/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 11/09/2024 tadalafil Tablet, film coated 10 mg Anticipated Available Manufacturing 11/09/2024 nebivolol hydrochloride Tablet 10.9 mg Current Unavailable Manufacturing 11/09/2024 nizatidine Capsule, hard 150 mg Current Unavailable Manufacturing 11/09/2024 dasatinib Tablet, film coated 100 mg Current Limited Availability Manufacturing 11/09/2024 ropinirole hydrochloride Tablet, film coated 2.28 mg Resolved Available Manufacturing 11/09/2024 linezolid Tablet, film coated 600 mg Current Limited Availability Unexpected increase in consumer demand 11/09/2024 lacosamide Tablet, film coated 50 mg Anticipated Available Manufacturing 11/09/2024 spironolactone Tablet, uncoated 100 mg Current Limited Availability Manufacturing 11/09/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 11/09/2024 nizatidine Capsule, hard 300 mg Current Unavailable Manufacturing 11/09/2024 paclitaxel Injection, concentrated 6 mg/mL Resolved Available Manufacturing 11/09/2024 baclofen Tablet, uncoated 25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 11/09/2024 escitalopram oxalate Tablet, film coated 25.56 mg Current Limited Availability Manufacturing 10/09/2024 dexamethasone~framycetin sulfate~gramicidin Ear Drops .5 mg/mL~5 mg/mL~.05 mg/mL Current Unavailable Manufacturing 10/09/2024 risperidone Tablet .5 mg Resolved Available Manufacturing 10/09/2024 risperidone Tablet 1 mg Resolved Available Manufacturing 10/09/2024 gabapentin Tablet, film coated 800 mg Current Unavailable Manufacturing 10/09/2024 hydrocortisone sodium succinate Injection, powder for 134 mg Resolved Available Manufacturing 10/09/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 10/09/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Resolved Available Manufacturing 10/09/2024 hydrochlorothiazide~telmisartan Tablet, film coated 12.5 mg~80 mg Current Limited Availability Manufacturing 10/09/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 10/09/2024 amlodipine besilate Tablet 13.87 mg Resolved Available Manufacturing 10/09/2024 ezetimibe Tablet, uncoated 10 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 10/09/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 10/09/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 10/09/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Manufacturing 10/09/2024 clonidine hydrochloride Tablet 100 microgram Current Unavailable Unexpected increase in consumer demand 10/09/2024 cinacalcet hydrochloride Tablet, film coated 33 mg Resolved Available Manufacturing 10/09/2024 tenofovir disoproxil fumarate Tablet 300 mg Current Unavailable Manufacturing 10/09/2024 ezetimibe~simvastatin Tablet 10 mg~20 mg Resolved Available Manufacturing 10/09/2024 mesalazine Tablet, enteric coated 1.6 g Current Unavailable Transport / Logistic issues / Storage capacity issues 10/09/2024 bendamustine hydrochloride monohydrate Injection, powder for 100 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 10/09/2024 rosuvastatin calcium Tablet, film coated 5.21 mg Resolved Available Manufacturing 10/09/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 10/09/2024 indometacin Capsule, hard 25 mg Current Limited Availability Manufacturing 10/09/2024 temozolomide Capsule, hard 5 mg Current Limited Availability Manufacturing 10/09/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Unavailable Manufacturing 10/09/2024 lanreotide acetate Injection, solution 100 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 10/09/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 10/09/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 10/09/2024 ezetimibe~rosuvastatin calcium Tablet 10 mg~10.4 mg Current Unavailable Manufacturing 10/09/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.6 mg Current Limited Availability Manufacturing 10/09/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.8 mg Current Unavailable Manufacturing 10/09/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 10/09/2024 heparin sodium Injection, solution 5000 IU/mL Anticipated Available Manufacturing 10/09/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 10/09/2024 azithromycin dihydrate Suspension, powder for 209.65 mg Current Unavailable Unexpected increase in consumer demand 10/09/2024 indapamide hemihydrate Tablet 2.5 mg Current Limited Availability Manufacturing 10/09/2024 salbutamol sulfate Inhalation 1.2 mg/mL Resolved Available Manufacturing 9/09/2024 fentanyl Drug delivery system, transdermal 2.063 mg Discontinued Unavailable Commercial Changes / Commercial viability 9/09/2024 fentanyl Drug delivery system, transdermal 8.25 mg Discontinued Unavailable Commercial Changes / Commercial viability 9/09/2024 fentanyl Drug delivery system, transdermal 12.375 mg Discontinued Unavailable Commercial Changes / Commercial viability 9/09/2024 galantamine hydrobromide Capsule, modified release 20.512 mg Resolved Available Manufacturing 9/09/2024 hydrocortisone sodium succinate Injection, powder for 334.25 mg Current Limited Availability Manufacturing 9/09/2024 bosentan monohydrate Tablet, film coated 64.541 mg Resolved Available Manufacturing 9/09/2024 midazolam Injection, solution 5 mg/mL Current Limited Availability Manufacturing 9/09/2024 midazolam Injection, solution 1 mg/mL Anticipated Available Manufacturing 9/09/2024 - 2024.09.09
Active ingredients Dosage form Quantity of active ingredients Availability Reason Last updated mycophenolate mofetil Tablet, film coated 500 mg Limited Availability Manufacturing 6/09/2024 methotrexate Injection, solution 100 mg/mL Limited Availability Manufacturing 6/09/2024 Follitropin alfa Injection, solution 225 IU Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/09/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.819 mg Unavailable Manufacturing 6/09/2024 eftrenonacog alfa Injection, powder for 4000 IU Unavailable Manufacturing 6/09/2024 estradiol Drug delivery system, transdermal 1.17 mg Unavailable Manufacturing 6/09/2024 iopromide Injection, solution 498.72 mg/mL Unavailable Unexpected increase in consumer demand 6/09/2024 ezetimibe Tablet 10 mg Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/09/2024 norethisterone Tablet, uncoated 350 microgram Available Manufacturing 5/09/2024 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Available Manufacturing 5/09/2024 calcium folinate Injection 324.1 mg Available Manufacturing 5/09/2024 lincomycin hydrochloride monohydrate Injection, solution 340.26 mg/mL Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 5/09/2024 griseofulvin Tablet, uncoated 125 mg Unavailable Manufacturing 5/09/2024 adrenaline (epinephrine) Injection, solution 1 mg Limited Availability Manufacturing 5/09/2024 anidulafungin Injection, powder for 100 mg Limited Availability Manufacturing 5/09/2024 framycetin sulfate~dexamethasone~gramicidin Ear Drops 5 mg/mL~.5 mg/mL~.05 mg/mL Unavailable Manufacturing 5/09/2024 adrenaline (epinephrine) Injection, solution 1 mg Available Manufacturing 5/09/2024 latanoprost~timolol maleate Eye Drops, solution 50 microgram/mL~6.83 mg/mL Available Unexpected increase in consumer demand 5/09/2024 azacitidine Injection, powder for 100 mg Available Manufacturing 5/09/2024 tadalafil Tablet, film coated 20 mg Limited Availability Manufacturing 5/09/2024 flucloxacillin sodium monohydrate Injection, powder for 1088.1 mg Limited Availability Transport / Logistic issues / Storage capacity issues 5/09/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Available Unexpected increase in consumer demand 5/09/2024 tobramycin Inhalation, conventional 60 mg/mL Unavailable Manufacturing 5/09/2024 clarithromycin Tablet, film coated 250 mg Limited Availability Manufacturing 4/09/2024 fludarabine phosphate Injection, concentrated 50 mg Unavailable Manufacturing 4/09/2024 clonidine hydrochloride Tablet, uncoated 100 microgram Limited Availability Manufacturing 4/09/2024 trandolapril Capsule, hard 1 mg Limited Availability Manufacturing 4/09/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Unavailable Manufacturing 4/09/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Unavailable Manufacturing 4/09/2024 Omalizumab Injection, solution 150 mg Available Manufacturing 4/09/2024 levetiracetam Injection, concentrated 500 mg Available Manufacturing 4/09/2024 mitomycin Injection, powder for 20 mg Limited Availability Manufacturing 4/09/2024 tenofovir disoproxil maleate~emtricitabine Tablet, film coated 300 mg~200 mg Limited Availability Manufacturing 4/09/2024 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Limited Availability Commercial Changes / Commercial viability 4/09/2024 celecoxib Capsule, hard 100 mg Limited Availability Manufacturing 4/09/2024 busulfan Injection, concentrated 60 mg Available Manufacturing 4/09/2024 emtricitabine~tenofovir disoproxil succinate Tablet, film coated 200 mg~300.6 mg Unavailable Manufacturing 4/09/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Unavailable Unexpected increase in demand due to other sponsors unable to supply 4/09/2024 erythromycin ethyl succinate Oral Liquid, powder for 468 mg Limited Availability Unexpected increase in consumer demand 4/09/2024 clonazepam Tablet, uncoated .5 mg Available Manufacturing 4/09/2024 captopril Tablet, uncoated 25 mg Unavailable Manufacturing 4/09/2024 captopril Tablet, uncoated 50 mg Unavailable Manufacturing 4/09/2024 clindamycin phosphate Lotion 10 mg/mL Available Manufacturing 4/09/2024 rizatriptan benzoate Wafer 14.53 mg Limited Availability Manufacturing 4/09/2024 leuprorelin acetate Injection, modified release 45 mg Available Manufacturing 3/09/2024 ondansetron hydrochloride dihydrate Injection, solution 5 mg Available Manufacturing 3/09/2024 magnesium chloride hexahydrate~sodium chloride~sodium lactate~glucose~calcium chloride dihydrate Solution, irrigation 50.8 mg/L~5.38 g/L~4.48 g/L~15 g/L~183 mg/L Limited Availability Manufacturing 3/09/2024 olanzapine Tablet, orally disintegrating 10 mg Unavailable Commercial Changes / Commercial viability 3/09/2024 capecitabine Tablet, film coated 500 mg Unavailable Manufacturing 3/09/2024 paracetamol Injection, solution 10 mg/mL Available Unexpected increase in consumer demand 3/09/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 41.583 mg~10 mg Limited Availability Manufacturing 3/09/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 20.791 mg~10 mg Limited Availability Manufacturing 3/09/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 20.791 mg~10 mg Available Manufacturing 3/09/2024 oxytocin Injection, solution 10 IU/mL Available Transport / Logistic issues / Storage capacity issues 3/09/2024 fluorouracil Injection, solution 50 mg/mL Unavailable Manufacturing 3/09/2024 lacosamide Tablet, film coated 50 mg Unavailable Manufacturing 3/09/2024 letrozole Tablet, film coated 2.5 mg Limited Availability Manufacturing 3/09/2024 mesalazine Tablet, enteric coated 1.6 g Available Transport / Logistic issues / Storage capacity issues 3/09/2024 carmustine Injection, powder for 100 mg Limited Availability Manufacturing 3/09/2024 betahistine dihydrochloride Tablet 16 mg Unavailable Unexpected increase in consumer demand 3/09/2024 clonazepam Tablet, uncoated 2 mg Limited Availability Manufacturing 3/09/2024 azithromycin dihydrate Tablet, film coated 628.93 mg Unavailable Manufacturing 3/09/2024 leuprorelin acetate Injection, modified release 22.5 mg Available Manufacturing 3/09/2024 propranolol hydrochloride Tablet, film coated 40 mg Available Manufacturing 2/09/2024 primidone Tablet, uncoated 250 mg Available Manufacturing 2/09/2024 povidoneiodine Application 100 mg/mL Available Manufacturing 2/09/2024 donepezil hydrochloride Tablet, film coated 10 mg Unavailable Transport / Logistic issues / Storage capacity issues 2/09/2024 donepezil hydrochloride Tablet, film coated 5 mg Available Transport / Logistic issues / Storage capacity issues 2/09/2024 magnesium chloride hexahydrate~calcium chloride dihydrate~sodium lactate~glucose~sodium chloride Solution, irrigation 50.8 mg/L~183 mg/L~4.48 g/L~25 g/L~5.38 g/L Limited Availability Manufacturing 2/09/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~10.396 mg Unavailable Manufacturing 2/09/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 10.396 mg~10 mg Unavailable Manufacturing 2/09/2024 solifenacin succinate Tablet, film coated 5 mg Unavailable Manufacturing 2/09/2024 solifenacin succinate Tablet, film coated 10 mg Unavailable Manufacturing 2/09/2024 methylphenidate hydrochloride Tablet, modified release 54 mg Available Manufacturing 2/09/2024 nizatidine Capsule, hard 300 mg Available Manufacturing 2/09/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 2.7 mg~.62 mg Unavailable Manufacturing 2/09/2024 - 2024.09.02
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated pioglitazone hydrochloride Tablet, uncoated 33.06 mg Anticipated Available Manufacturing 1/09/2024 atropine sulfate monohydrate Injection, solution 1.2 mg/mL Current Unavailable Manufacturing 30/08/2024 gentamicin Injection, solution 80 mg Anticipated Available Manufacturing 30/08/2024 pantoprazole sodium sesquihydrate Injection, powder for 45.12 mg Current Unavailable Manufacturing 30/08/2024 griseofulvin Tablet 500 mg Resolved Available Manufacturing 30/08/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 30/08/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 30/08/2024 adrenaline (epinephrine) Injection, solution 1 mg Current Limited Availability Manufacturing 30/08/2024 Choriogonadotropin alfa Injection, solution 250 microgram Current Limited Availability Unexpected increase in consumer demand 30/08/2024 Alteplase Injection, powder for 50 mg Resolved Available Unexpected increase in consumer demand 30/08/2024 montelukast sodium Tablet, film coated 10.4 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/08/2024 hydrochlorothiazide~telmisartan Tablet, film coated 12.5 mg~80 mg Current Limited Availability Manufacturing 30/08/2024 temozolomide Capsule, hard 100 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 30/08/2024 metformin hydrochloride Tablet, modified release 1000 mg Current Limited Availability Manufacturing 30/08/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 30/08/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Unavailable Manufacturing 30/08/2024 epirubicin hydrochloride Injection, concentrated 200 mg Current Unavailable Manufacturing 30/08/2024 azithromycin dihydrate Tablet, film coated 524 mg Anticipated Available Manufacturing 30/08/2024 betahistine dihydrochloride Tablet 16 mg Current Unavailable Manufacturing 30/08/2024 bortezomib Injection, powder for 2.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 30/08/2024 tadalafil Tablet, film coated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 30/08/2024 lisdexamfetamine dimesilate Capsule, hard 60 mg Current Unavailable Unexpected increase in consumer demand 30/08/2024 timolol maleate Eye Drops, solution 6.83 mg/mL Anticipated Available Commercial Changes / Commercial viability 30/08/2024 ropinirole hydrochloride Tablet, film coated 2.28 mg Current Unavailable Manufacturing 30/08/2024 tenofovir disoproxil fumarate Tablet 300 mg Current Limited Availability Manufacturing 30/08/2024 celecoxib Capsule, hard 100 mg Anticipated Available Manufacturing 30/08/2024 hydromorphone hydrochloride Injection, solution 2 mg Anticipated Available Manufacturing 30/08/2024 lenalidomide Capsule, hard 5 mg Current Limited Availability Unexpected increase in consumer demand 30/08/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~13.88 mg Current Unavailable Manufacturing 30/08/2024 tirzepatide Injection, solution 5 mg Current Limited Availability Commercial Changes / Commercial viability 30/08/2024 tirzepatide Injection, solution 7.5 mg Current Limited Availability Commercial Changes / Commercial viability 30/08/2024 tirzepatide Injection, solution 12.5 mg Current Limited Availability Commercial Changes / Commercial viability 30/08/2024 tirzepatide Injection, solution 10 mg Current Limited Availability Commercial Changes / Commercial viability 30/08/2024 tirzepatide Injection, solution 15 mg Current Unavailable Commercial Changes / Commercial viability 30/08/2024 tirzepatide Injection, solution 2.5 mg Current Limited Availability Commercial Changes / Commercial viability 30/08/2024 amidotrizoate meglumine~sodium amidotrizoate Injection, intravenous infusion 260 mg/mL~40 mg/mL Current Unavailable Manufacturing 30/08/2024 sodium chloride Injection, solution 90 mg Current Limited Availability Manufacturing 30/08/2024 sodium chloride Injection, intravenous infusion 900 mg Current Unavailable Manufacturing 30/08/2024 timolol maleate Eye Drops, solution 6.84 mg/mL Current Unavailable Manufacturing 30/08/2024 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Anticipated Available Manufacturing 30/08/2024 Alteplase Diluent, not applicable 10 mg Resolved Available Unexpected increase in consumer demand 30/08/2024 timolol maleate~dorzolamide hydrochloride Eye Drops, solution 6.83 mg/mL~22.26 mg/mL Current Unavailable Manufacturing 30/08/2024 rizatriptan benzoate Wafer 14.53 mg Anticipated Available Manufacturing 30/08/2024 prazosin hydrochloride Tablet, uncoated 5.5 mg Current Unavailable Manufacturing 30/08/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 30/08/2024 sevelamer hydrochloride Tablet, film coated 800 mg Resolved Available Manufacturing 29/08/2024 bendamustine hydrochloride monohydrate Injection, powder for 100 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/08/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Anticipated Available Unexpected increase in consumer demand 29/08/2024 phytomenadione Injection, solution 10 mg/mL Resolved Available Product recall 29/08/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/08/2024 zopiclone Tablet, film coated 7.5 mg Resolved Available Manufacturing 29/08/2024 escitalopram oxalate Tablet, film coated 25.56 mg Current Limited Availability Manufacturing 28/08/2024 amlodipine besilate Tablet, uncoated 6.94 mg Resolved Available Manufacturing 28/08/2024 trihexyphenidyl (benzhexol) hydrochloride Tablet, uncoated 5 mg Resolved Available Manufacturing 28/08/2024 ondansetron hydrochloride dihydrate Injection, solution 10 mg Resolved Available Manufacturing 28/08/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Resolved Available Manufacturing 28/08/2024 clonidine hydrochloride Tablet, uncoated 100 microgram Anticipated Available Manufacturing 28/08/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 28/08/2024 bicalutamide Tablet, film coated 50 mg Anticipated Available Manufacturing 28/08/2024 trandolapril Capsule, hard .5 mg Current Limited Availability Manufacturing 28/08/2024 trandolapril Capsule, hard 1 mg Anticipated Available Manufacturing 28/08/2024 trandolapril Capsule, hard 2 mg Current Limited Availability Manufacturing 28/08/2024 trandolapril Capsule, hard 4 mg Current Limited Availability Manufacturing 28/08/2024 Abatacept Injection 125.875 mg Resolved Available Unexpected increase in consumer demand 28/08/2024 timolol maleate~latanoprost Eye Drops, solution 6.83 mg/mL~50 microgram/mL Current Unavailable Unexpected increase in consumer demand 28/08/2024 paclitaxel Injection, concentrated 300 mg Current Unavailable Manufacturing 28/08/2024 conjugated estrogens~bazedoxifene acetate Tablet, modified release .45 mg~22.56 mg Current Unavailable Commercial Changes / Commercial viability 28/08/2024 cinacalcet hydrochloride Tablet 33.064 mg Resolved Available Manufacturing 28/08/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Unavailable Manufacturing 28/08/2024 lacosamide Tablet, film coated 150 mg Anticipated Available Manufacturing 28/08/2024 nebivolol hydrochloride Tablet 1.363 mg Current Unavailable Manufacturing 28/08/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 28/08/2024 nebivolol hydrochloride Tablet 10.9 mg Current Limited Availability Manufacturing 28/08/2024 mycophenolate mofetil Tablet, film coated 500 mg Resolved Available Manufacturing 28/08/2024 mycophenolate mofetil Injection, powder for 500 mg Current Unavailable Manufacturing 28/08/2024 dasatinib propylene glycol Tablet, film coated 116 mg Current Limited Availability Manufacturing 28/08/2024 sitagliptin fumarate Tablet, film coated 128.497 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 28/08/2024 lanreotide acetate Injection, solution 133.33 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 28/08/2024 octreotide Injection, solution 100 microgram/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 28/08/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 28/08/2024 vincristine sulfate Injection, solution 1 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 28/08/2024 indapamide hemihydrate Tablet 2.5 mg Anticipated Available Manufacturing 28/08/2024 zolpidem tartrate Tablet, film coated 10 mg Resolved Available Manufacturing 27/08/2024 lidocaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate Injection, solution 21.3 mg/mL~22.7 microgram/mL Resolved Available Manufacturing 27/08/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Unavailable Manufacturing 27/08/2024 salbutamol sulfate Inhalation 1.2 mg/mL Anticipated Available Manufacturing 27/08/2024 risperidone Tablet .5 mg Current Unavailable Manufacturing 27/08/2024 risperidone Tablet 1 mg Current Unavailable Manufacturing 27/08/2024 ondansetron hydrochloride dihydrate Injection, solution 5 mg Current Unavailable Manufacturing 27/08/2024 dopamine hydrochloride Injection, concentrated 40 mg/mL Anticipated Available Manufacturing 27/08/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 27/08/2024 bisoprolol fumarate Tablet 2.5 mg Current Limited Availability Manufacturing 27/08/2024 ropivacaine hydrochloride Injection, solution 400 mg Resolved Available Transport / Logistic issues / Storage capacity issues 27/08/2024 zolmitriptan Tablet, film coated 2.5 mg Anticipated Available Manufacturing 27/08/2024 quetiapine fumarate Tablet, film coated 115.12 mg Anticipated Available Manufacturing 27/08/2024 simvastatin Tablet, film coated 20 mg Resolved Available Manufacturing 27/08/2024 pemetrexed disodium Injection, powder for 110.28 mg Current Unavailable Manufacturing 27/08/2024 pemetrexed disodium Injection, powder for 551.4 mg Current Unavailable Manufacturing 27/08/2024 pemetrexed disodium Injection, powder for 1102.8 mg Current Unavailable Manufacturing 27/08/2024 rosuvastatin calcium Tablet, film coated 41.68 mg Resolved Available Commercial Changes / Commercial viability 27/08/2024 voriconazole Injection, powder for 200 mg Current Unavailable Manufacturing 27/08/2024 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Current Limited Availability Commercial Changes / Commercial viability 27/08/2024 metformin hydrochloride Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 27/08/2024 risperidone Oral Liquid, solution 1 mg/mL Current Unavailable Manufacturing 27/08/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 27/08/2024 nebivolol hydrochloride Tablet 10.9 mg Current Unavailable Manufacturing 27/08/2024 montelukast sodium Tablet, film coated 10.4 mg Resolved Available Unexpected increase in consumer demand 27/08/2024 mycophenolate sodium Tablet, enteric coated 384.7 mg Anticipated Available Manufacturing 27/08/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 27/08/2024 carmustine Injection, powder for 100 mg Current Limited Availability Manufacturing 27/08/2024 cefaclor monohydrate Oral Liquid, powder for 26.22 mg/mL Resolved Available Manufacturing 27/08/2024 sodium valproate Tablet, enteric coated 500 mg Resolved Available Manufacturing 27/08/2024 clonazepam Tablet, uncoated 2 mg Current Limited Availability Manufacturing 27/08/2024 captopril Tablet, uncoated 50 mg Current Unavailable Manufacturing 27/08/2024 flecainide acetate Tablet, uncoated 100 mg Resolved Available Manufacturing 27/08/2024 enalapril maleate Tablet, uncoated 5 mg Resolved Available Manufacturing 27/08/2024 ciprofloxacin hydrochloride Tablet, film coated 873.32 mg Anticipated Available Manufacturing 27/08/2024 metformin hydrochloride Tablet, film coated 500 mg Resolved Available Manufacturing 27/08/2024 metformin hydrochloride Tablet, film coated 1000 mg Resolved Available Manufacturing 27/08/2024 baclofen Tablet, uncoated 25 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 27/08/2024 famotidine Tablet, film coated 20 mg Current Unavailable Manufacturing 27/08/2024 famotidine Tablet, film coated 40 mg Current Unavailable Manufacturing 27/08/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Resolved Available Manufacturing 27/08/2024 metformin hydrochloride Tablet, modified release 500 mg Discontinued Unavailable Manufacturing 26/08/2024 perindopril erbumine Tablet, uncoated 2 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/08/2024 perindopril erbumine Tablet, uncoated 4 mg Discontinued Unavailable Commercial Changes / Commercial viability 26/08/2024 perindopril erbumine Tablet, uncoated 8 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/08/2024 Epoetin lambda Injection, solution 10000 IU Current Limited Availability Manufacturing 26/08/2024 gabapentin Tablet, film coated 600 mg Anticipated Available Manufacturing 26/08/2024 insulin~insulin Injection, suspension 30 IU/mL~70 IU/mL Discontinued Unavailable Commercial Changes / Commercial viability 26/08/2024 perindopril erbumine Tablet 8 mg Resolved Available Manufacturing 26/08/2024 bisoprolol fumarate Tablet 5 mg Anticipated Available Manufacturing 26/08/2024 bisoprolol fumarate Tablet 10 mg Anticipated Available Manufacturing 26/08/2024 bosentan monohydrate Tablet, film coated 64.541 mg Current Unavailable Manufacturing 26/08/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Manufacturing 26/08/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 26/08/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 26/08/2024 dasatinib Tablet, film coated 70 mg Current Limited Availability Commercial Changes / Commercial viability 26/08/2024 atomoxetine hydrochloride Capsule, hard 45.5 mg Current Unavailable Manufacturing 26/08/2024 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 26/08/2024 bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate Injection, solution 5.27 mg/mL~9.1 microgram/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 26/08/2024 estradiol Drug delivery system, transdermal 1.56 mg Current Limited Availability Manufacturing 26/08/2024 - 2024.08.26
Active ingredients Dosage form Quantity of active ingredients Availability Reason Last updated clarithromycin Tablet, film coated 250 mg Limited Availability Manufacturing 23/08/2024 isosorbide dinitrate Tablet, uncoated 5 mg Available Manufacturing 23/08/2024 adrenaline (epinephrine) Injection, solution 1 mg Limited Availability Manufacturing 23/08/2024 gliclazide Tablet, modified release 30 mg Available Manufacturing 23/08/2024 oxazepam Tablet, uncoated 15 mg Unavailable Manufacturing 23/08/2024 Omalizumab Injection, solution 150 mg Unavailable Manufacturing 23/08/2024 efmoroctocog alfa Injection, powder for 250 IU Available Manufacturing 23/08/2024 timolol maleate~latanoprost Eye Drops, solution 6.83 mg/mL~50 microgram/mL Unavailable Unexpected increase in consumer demand 23/08/2024 olopatadine hydrochloride Eye Drops 1.11 mg/mL Unavailable Manufacturing 23/08/2024 temozolomide Capsule, hard 5 mg Unavailable Manufacturing 23/08/2024 ezetimibe Tablet, uncoated 10 mg Unavailable Manufacturing 23/08/2024 tadalafil Tablet, film coated 5 mg Unavailable Manufacturing 23/08/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Limited Availability Manufacturing 23/08/2024 fenofibrate Tablet 145 mg Available Manufacturing 23/08/2024 busulfan Injection, concentrated 60 mg Unavailable Manufacturing 23/08/2024 letrozole Tablet, film coated 2.5 mg Available Manufacturing 23/08/2024 bendamustine hydrochloride monohydrate Injection, powder for 25 mg Available Unexpected increase in demand due to other sponsors unable to supply 23/08/2024 difelikefalin acetate Injection, solution 55 microgram Available Manufacturing 23/08/2024 enoxaparin sodium Injection, solution 40 mg Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/08/2024 enoxaparin sodium Injection, solution 120 mg Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/08/2024 dexamethasone~framycetin sulfate~gramicidin Ear Drops .5 mg/mL~5 mg/mL~.05 mg/mL Available Manufacturing 23/08/2024 tobramycin Inhalation, conventional 60 mg/mL Unavailable Manufacturing 23/08/2024 pamidronate disodium Injection, concentrated 9 mg Available Manufacturing 23/08/2024 paclitaxel Injection, concentrated 6 mg/mL Limited Availability Manufacturing 23/08/2024 ampicillin Injection, powder for 1 g Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/08/2024 Filgrastim Injection, solution 480 microgram Limited Availability Transport / Logistic issues / Storage capacity issues 22/08/2024 metoprolol succinate Tablet, modified release 95 mg Available Manufacturing 22/08/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Limited Availability Manufacturing 22/08/2024 quetiapine fumarate Tablet, film coated 115.12 mg Available Manufacturing 22/08/2024 quetiapine fumarate Tablet, film coated 345.36 mg Unavailable Manufacturing 22/08/2024 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Available Manufacturing 22/08/2024 nizatidine Capsule, hard 150 mg Unavailable Manufacturing 22/08/2024 ropinirole hydrochloride Tablet, film coated 2.28 mg Unavailable Manufacturing 22/08/2024 dostarlimab Injection, intravenous infusion 500 mg/mL Limited Availability Unexpected increase in consumer demand 22/08/2024 estradiol~norethisterone acetate Drug delivery system, transdermal .512 mg~4.8 mg Available Manufacturing 22/08/2024 nizatidine Capsule, hard 300 mg Unavailable Manufacturing 22/08/2024 fentanyl Drug delivery system, transdermal 4.2 mg Unavailable Manufacturing 21/08/2024 fentanyl Drug delivery system, transdermal 8.4 mg Unavailable Manufacturing 21/08/2024 fentanyl Drug delivery system, transdermal 12.6 mg Unavailable Manufacturing 21/08/2024 fentanyl Drug delivery system, transdermal 16.8 mg Unavailable Manufacturing 21/08/2024 fentanyl Drug delivery system, transdermal 2.1 mg Unavailable Manufacturing 21/08/2024 lisdexamfetamine dimesilate Capsule, hard 20 mg Available Unexpected increase in consumer demand 21/08/2024 cinacalcet hydrochloride Tablet 33.064 mg Unavailable Manufacturing 21/08/2024 cinacalcet hydrochloride Tablet 66.127 mg Available Manufacturing 21/08/2024 rifampicin Capsule, hard 150 mg Available Manufacturing 21/08/2024 escitalopram oxalate Tablet, film coated 25.56 mg Limited Availability Manufacturing 20/08/2024 amlodipine besilate Tablet, uncoated 6.94 mg Limited Availability Manufacturing 20/08/2024 alendronate sodium Tablet 91.37 mg Available Manufacturing 20/08/2024 galantamine hydrobromide Capsule, modified release 20.512 mg Unavailable Manufacturing 20/08/2024 Filgrastim Injection, solution 120 microgram Limited Availability Transport / Logistic issues / Storage capacity issues 20/08/2024 donepezil hydrochloride Tablet, film coated 10 mg Available Manufacturing 20/08/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/08/2024 oxycodone hydrochloride Capsule, hard 10 mg Available Commercial Changes / Commercial viability 20/08/2024 oxycodone hydrochloride Capsule, hard 20 mg Unavailable Commercial Changes / Commercial viability 20/08/2024 oxycodone hydrochloride Capsule, hard 5 mg Available Commercial Changes / Commercial viability 20/08/2024 gliclazide Tablet, modified release 30 mg Limited Availability Unexpected increase in demand due to other sponsors unable to supply 20/08/2024 Rabies virus Injection, powder for 2.5 IU Emergency Supply Only Manufacturing 20/08/2024 risperidone Oral Liquid, solution 1 mg/mL Unavailable Manufacturing 20/08/2024 spironolactone Tablet, uncoated 100 mg Limited Availability Manufacturing 20/08/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Unavailable Manufacturing 20/08/2024 flecainide acetate Tablet 50 mg Unavailable Manufacturing 20/08/2024 indometacin Capsule, hard 25 mg Limited Availability Manufacturing 20/08/2024 paracetamol Tablet, modified release 665 mg Limited Availability Transport / Logistic issues / Storage capacity issues 20/08/2024 oxazepam Tablet, uncoated 30 mg Unavailable Manufacturing 20/08/2024 captopril Tablet, uncoated 25 mg Unavailable Manufacturing 20/08/2024 pravastatin sodium Tablet, uncoated 40 mg Limited Availability Manufacturing 20/08/2024 morphine hydrochloride trihydrate Oral Liquid, solution 1 mg/mL Unavailable Commercial Changes / Commercial viability 19/08/2024 morphine hydrochloride trihydrate Oral Liquid, solution 2 mg/mL Unavailable Commercial Changes / Commercial viability 19/08/2024 morphine hydrochloride trihydrate Oral Liquid, solution 5 mg/mL Unavailable Commercial Changes / Commercial viability 19/08/2024 Choriogonadotropin alfa Injection, solution 250 microgram Limited Availability Unexpected increase in consumer demand 19/08/2024 carmustine Injection, powder for 100 mg Unavailable Manufacturing 19/08/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Unavailable Manufacturing 19/08/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Unavailable Manufacturing 19/08/2024 nortriptyline hydrochloride Tablet, uncoated 28.5 mg Unavailable Manufacturing 19/08/2024 nortriptyline hydrochloride Tablet, uncoated 11.4 mg Unavailable Manufacturing 19/08/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.935 mg Available Manufacturing 19/08/2024 lacosamide Tablet, film coated 50 mg Available Manufacturing 19/08/2024 montelukast sodium Tablet, chewable 5.2 mg Available Manufacturing 19/08/2024 montelukast sodium Tablet, chewable 4.16 mg Available Manufacturing 19/08/2024 carbachol Injection, solution 100 microgram/mL Limited Availability Unexpected increase in demand due to other sponsors unable to supply 19/08/2024 clonazepam Tablet, uncoated 2 mg Available Manufacturing 19/08/2024 mianserin hydrochloride Tablet, film coated 20 mg Available Manufacturing 19/08/2024 estradiol hemihydrate Drug delivery system, transdermal 1.54 mg Available Unexpected increase in demand due to other sponsors unable to supply 19/08/2024 estradiol hemihydrate Drug delivery system, transdermal .77 mg Available Commercial Changes / Commercial viability 19/08/2024 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Available Unexpected increase in demand due to other sponsors unable to supply 19/08/2024 - 2024.08.20
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated ondansetron hydrochloride dihydrate Injection, solution 5 mg Current Unavailable Manufacturing 16/08/2024 azithromycin dihydrate Tablet, film coated 524.05 mg Anticipated Available Manufacturing 16/08/2024 hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil Tablet 25 mg~6.944 mg~40 mg Current Unavailable Manufacturing 16/08/2024 latanoprost Eye Drops, solution 50 microgram/mL Resolved Available Unexpected increase in consumer demand 16/08/2024 acarbose Tablet 50 mg Current Unavailable Manufacturing 16/08/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 16/08/2024 cefuroxime axetil Tablet, film coated 300.715 mg Resolved Available Unexpected increase in consumer demand 16/08/2024 paracetamol Injection 1 g Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/08/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Limited Availability Manufacturing 16/08/2024 bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate Injection, solution 2.64 mg/mL~4.5 microgram/mL Resolved Available Manufacturing 16/08/2024 cinacalcet hydrochloride Tablet, film coated 33 mg Current Limited Availability Manufacturing 16/08/2024 lanreotide acetate Injection, solution 100 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 16/08/2024 erythromycin ethyl succinate Oral Liquid, powder for 468 mg Anticipated Available Unexpected increase in consumer demand 16/08/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Resolved Available Manufacturing 16/08/2024 clindamycin phosphate Lotion 10 mg/mL Anticipated Available Manufacturing 16/08/2024 pamidronate disodium Injection, concentrated 9 mg Current Limited Availability Manufacturing 16/08/2024 ezetimibe Tablet 10 mg Resolved Available Unexpected increase in consumer demand 16/08/2024 methylphenidate hydrochloride Tablet, modified release 36 mg Current Limited Availability Manufacturing 16/08/2024 povidoneiodine Application 100 mg/mL Current Limited Availability Manufacturing 15/08/2024 risperidone Tablet, film coated 4 mg Anticipated Available Manufacturing 15/08/2024 donepezil hydrochloride Tablet, film coated 5 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 15/08/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Anticipated Available Manufacturing 15/08/2024 valaciclovir hydrochloride monohydrate Tablet, film coated 611.7 mg Discontinued Unavailable Commercial Changes / Commercial viability 15/08/2024 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 15/08/2024 sildenafil citrate Tablet, film coated 28.1 mg Current Limited Availability Manufacturing 15/08/2024 enalapril maleate Tablet 10 mg Resolved Available Manufacturing 15/08/2024 quetiapine fumarate Tablet, film coated 345.36 mg Current Unavailable Manufacturing 15/08/2024 temozolomide Capsule, hard 5 mg Current Unavailable Manufacturing 15/08/2024 temozolomide Capsule, hard 180 mg Resolved Available Manufacturing 15/08/2024 rosuvastatin calcium Tablet, film coated 5.21 mg Resolved Available Manufacturing 15/08/2024 olmesartan medoxomil Tablet 40 mg Resolved Available Manufacturing 15/08/2024 ezetimibe Tablet, uncoated 10 mg Anticipated Available Manufacturing 15/08/2024 irbesartan Tablet, film coated 150 mg Anticipated Available Manufacturing 15/08/2024 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Anticipated Available Manufacturing 15/08/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 15/08/2024 metformin hydrochloride Tablet, film coated 850 mg Current Unavailable Manufacturing 15/08/2024 hydrochlorothiazide~olmesartan medoxomil Tablet 25 mg~40 mg Resolved Available Manufacturing 15/08/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 15/08/2024 dasatinib Tablet, film coated 100 mg Current Limited Availability Manufacturing 15/08/2024 latanoprost Eye Drops, solution .05 mg/mL Current Limited Availability Transport / Logistic issues / Storage capacity issues 15/08/2024 lacosamide Tablet, film coated 150 mg Anticipated Available Manufacturing 15/08/2024 estradiol Drug delivery system, transdermal .39 mg Current Unavailable Manufacturing 15/08/2024 estradiol Drug delivery system, transdermal .585 mg Current Unavailable Manufacturing 15/08/2024 estradiol Drug delivery system, transdermal .78 mg Current Unavailable Manufacturing 15/08/2024 estradiol Drug delivery system, transdermal 1.56 mg Current Unavailable Manufacturing 15/08/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 41.6 mg~10 mg Current Limited Availability Manufacturing 15/08/2024 lidocaine hydrochloride~adrenaline (epinephrine) acid tartrate Injection, solution 5 mg/mL~9.1 microgram/mL Discontinued Unavailable Manufacturing 14/08/2024 adrenaline (epinephrine) Injection, solution 1 mg Current Limited Availability Manufacturing 14/08/2024 anidulafungin Injection, powder for 100 mg Anticipated Available Manufacturing 14/08/2024 adrenaline (epinephrine) Injection, solution 1 mg Current Limited Availability Manufacturing 14/08/2024 efmoroctocog alfa Injection, powder for 250 IU Current Unavailable Manufacturing 14/08/2024 Insulin aspart Injection, solution 100 U/mL Resolved Available Transport / Logistic issues / Storage capacity issues 14/08/2024 cinacalcet hydrochloride Tablet, film coated 66 mg Resolved Available Manufacturing 14/08/2024 cinacalcet hydrochloride Tablet, film coated 99 mg Resolved Available Manufacturing 14/08/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 14/08/2024 nizatidine Capsule, hard 300 mg Current Unavailable Manufacturing 14/08/2024 Coxiella burnetii Injection 5 microgram/mL Current Limited Availability Manufacturing 13/08/2024 zolpidem tartrate Tablet, film coated 10 mg Discontinued Unavailable Commercial Changes / Commercial viability 13/08/2024 eprosartan mesilate~hydrochlorothiazide Tablet, film coated 735.8 mg~12.5 mg Discontinued Unavailable Manufacturing 13/08/2024 insulin Injection, solution 100 IU/mL Resolved Available Manufacturing 13/08/2024 griseofulvin Tablet 500 mg Current Unavailable Manufacturing 13/08/2024 papaverine hydrochloride Injection, solution 12 mg/mL Anticipated Available Manufacturing 13/08/2024 clonidine hydrochloride Tablet, uncoated 100 microgram Anticipated Available Manufacturing 13/08/2024 ropivacaine hydrochloride Injection, solution 400 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 13/08/2024 olmesartan medoxomil~hydrochlorothiazide~amlodipine besilate Tablet 40 mg~12.5 mg~6.944 mg Resolved Available Manufacturing 13/08/2024 capecitabine Tablet, film coated 500 mg Anticipated Available Manufacturing 13/08/2024 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 13/08/2024 codeine phosphate hemihydrate~doxylamine succinate~paracetamol Tablet, uncoated 10 mg~5.1 mg~500 mg Current Unavailable Manufacturing 13/08/2024 bosentan monohydrate Tablet, film coated 64.541 mg Current Unavailable Manufacturing 13/08/2024 ezetimibe Tablet 10 mg Current Unavailable Manufacturing 13/08/2024 cisplatin Injection, concentrated 1 mg/mL Resolved Available Unexpected increase in consumer demand 13/08/2024 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 13/08/2024 dasatinib Tablet, film coated 70 mg Current Limited Availability Commercial Changes / Commercial viability 13/08/2024 mercaptopurine monohydrate Tablet 50 mg Resolved Available Manufacturing 13/08/2024 gefitinib Tablet, film coated 250 mg Current Unavailable Product recall 13/08/2024 iopromide Injection, solution 768.86 mg/mL Resolved Available Unexpected increase in consumer demand 13/08/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Resolved Available Manufacturing 13/08/2024 estradiol Drug delivery system, transdermal 1.17 mg Current Limited Availability Manufacturing 13/08/2024 lanreotide acetate Injection, solution 133.33 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 13/08/2024 dasatinib Tablet, film coated 50 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 13/08/2024 tirzepatide Injection, solution 5 mg Current Limited Availability Unexpected increase in consumer demand 13/08/2024 tirzepatide Injection, solution 7.5 mg Current Limited Availability Unexpected increase in consumer demand 13/08/2024 tirzepatide Injection, solution 12.5 mg Current Limited Availability Unexpected increase in consumer demand 13/08/2024 tirzepatide Injection, solution 10 mg Current Limited Availability Unexpected increase in consumer demand 13/08/2024 tirzepatide Injection, solution 15 mg Current Unavailable Unexpected increase in consumer demand 13/08/2024 tirzepatide Injection, solution 2.5 mg Current Limited Availability Unexpected increase in consumer demand 13/08/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Anticipated Available Unexpected increase in consumer demand 13/08/2024 flecainide acetate Tablet, uncoated 100 mg Current Limited Availability Manufacturing 13/08/2024 tobramycin Injection, solution 80 mg Discontinued Unavailable Commercial Changes / Commercial viability 12/08/2024 fentanyl Drug delivery system, transdermal 7.65 mg Discontinued Unavailable Commercial Changes / Commercial viability 12/08/2024 fentanyl Drug delivery system, transdermal 1.28 mg Discontinued Unavailable Commercial Changes / Commercial viability 12/08/2024 perindopril erbumine Tablet 8 mg Current Limited Availability Manufacturing 12/08/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Discontinued Unavailable Manufacturing 12/08/2024 clopidogrel hydrogen sulfate~aspirin Tablet 97.87 mg~100 mg Current Limited Availability Manufacturing 12/08/2024 Bevacizumab Injection, concentrated 25 mg/mL Current Limited Availability Commercial Changes / Commercial viability 12/08/2024 cefaclor monohydrate Oral Liquid, powder for 26.22 mg/mL Current Unavailable Manufacturing 12/08/2024 bortezomib Injection, solution 3.5 mg Current Unavailable Manufacturing 12/08/2024 fentanyl citrate Injection, solution 157 microgram Current Limited Availability Manufacturing 12/08/2024 eprosartan mesilate Tablet, film coated 400 mg Discontinued Unavailable Manufacturing 12/08/2024 doxycycline monohydrate Tablet, uncoated 104.1 mg Resolved Available Manufacturing 12/08/2024 heparin sodium Injection, solution 10 IU/mL Anticipated Available Manufacturing 12/08/2024 ketamine hydrochloride Injection, solution 115.3 mg/mL Resolved Available Manufacturing 12/08/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 2.7 mg~.62 mg Resolved Available Manufacturing 12/08/2024 - 2024.08.12
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated Coxiella burnetii Injection 50 microgram/mL Current Limited Availability Manufacturing 9/08/2024 lisinopril dihydrate Tablet, uncoated 10.89 mg Current Unavailable Manufacturing 9/08/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Manufacturing 9/08/2024 sodium fluoride Injection, concentrated 1 mg/mL Resolved Available Manufacturing 9/08/2024 Omalizumab Injection, solution 150 mg Current Emergency Supply Only Manufacturing 9/08/2024 metformin hydrochloride Tablet, modified release 1000 mg Resolved Available Manufacturing 9/08/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 9/08/2024 betahistine dihydrochloride Tablet, uncoated 16 mg Discontinued Unavailable Manufacturing 9/08/2024 acarbose Tablet 50 mg Anticipated Available Manufacturing 9/08/2024 mesalazine Tablet, enteric coated 800 mg Resolved Available Transport / Logistic issues / Storage capacity issues 9/08/2024 ezetimibe Tablet, uncoated 10 mg Anticipated Available Manufacturing 9/08/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 9/08/2024 cinacalcet hydrochloride Tablet 66.127 mg Current Unavailable Manufacturing 9/08/2024 dasatinib Tablet, film coated 50 mg Current Unavailable Manufacturing 9/08/2024 escitalopram oxalate Tablet, film coated 12.74 mg Current Unavailable Commercial Changes / Commercial viability 9/08/2024 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet, film coated 6.95 mg~40 mg~25 mg Current Unavailable Manufacturing 9/08/2024 hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil Tablet, film coated 12.5 mg~6.95 mg~40 mg Current Limited Availability Manufacturing 9/08/2024 gefitinib Tablet, film coated 250 mg Current Unavailable Product recall 9/08/2024 lacosamide Tablet, film coated 50 mg Resolved Available Manufacturing 9/08/2024 atovaquone~proguanil hydrochloride Tablet, film coated 62.5 mg~25 mg Resolved Available Manufacturing 9/08/2024 fluoxetine hydrochloride Capsule, hard 22.36 mg Resolved Available Manufacturing 9/08/2024 cabergoline Tablet, uncoated 2 mg Anticipated Available Manufacturing 9/08/2024 desonide Lotion .5 mg/g Resolved Available Manufacturing 9/08/2024 rizatriptan benzoate Wafer 14.53 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 9/08/2024 sodium oxidronate Injection, powder for 3.15 mg Resolved Available Manufacturing 9/08/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Anticipated Available Manufacturing 9/08/2024 zopiclone Tablet, film coated 7.5 mg Current Unavailable Manufacturing 9/08/2024 bicalutamide Tablet, film coated 50 mg Anticipated Available Manufacturing 8/08/2024 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 8/08/2024 temozolomide Capsule, hard 100 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 8/08/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Current Limited Availability Commercial Changes / Commercial viability 8/08/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 8/08/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 8/08/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.819 mg Current Unavailable Manufacturing 8/08/2024 teriflunomide Tablet, film coated 14 mg Anticipated Available Manufacturing 8/08/2024 olanzapine Tablet, uncoated 7.5 mg Resolved Available Manufacturing 8/08/2024 Bevacizumab Injection, concentrated 25 mg/mL Anticipated Available Commercial Changes / Commercial viability 8/08/2024 sitagliptin fumarate Tablet, film coated 64.249 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 8/08/2024 sodium valproate Tablet, enteric coated 500 mg Anticipated Available Manufacturing 8/08/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 8/08/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 8/08/2024 nizatidine Capsule, hard 300 mg Anticipated Available Manufacturing 8/08/2024 roxithromycin Tablet, film coated 150 mg Discontinued Unavailable Manufacturing 8/08/2024 roxithromycin Tablet, film coated 300 mg Discontinued Unavailable Manufacturing 8/08/2024 framycetin sulfate~gramicidin~dexamethasone Ear Drops 5 mg/mL~.05 mg/mL~.5 mg/mL Current Unavailable Manufacturing 7/08/2024 fluorouracil Cream 50 mg/g Resolved Available Manufacturing 7/08/2024 ketorolac trometamol Injection, solution 30 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/08/2024 risperidone Tablet .5 mg Current Unavailable Manufacturing 7/08/2024 risperidone Tablet 1 mg Current Unavailable Manufacturing 7/08/2024 prochlorperazine maleate Tablet 5 mg Resolved Available Manufacturing 7/08/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Current Unavailable Manufacturing 7/08/2024 fentanyl Drug delivery system, transdermal 10.2 mg Discontinued Unavailable Commercial Changes / Commercial viability 7/08/2024 ondansetron Tablet, orally disintegrating 4 mg Resolved Available Manufacturing 7/08/2024 mycophenolate mofetil Capsule, hard 250 mg Discontinued Unavailable Manufacturing 7/08/2024 sildenafil citrate Tablet, film coated 28.1 mg Resolved Available Manufacturing 7/08/2024 escitalopram oxalate Tablet, film coated 12.74 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 7/08/2024 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 7/08/2024 Abatacept Injection 125.875 mg Resolved Available Manufacturing 7/08/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 7/08/2024 imatinib mesilate Capsule, hard 119.47 mg Resolved Available Manufacturing 7/08/2024 clonidine hydrochloride Tablet 100 microgram Anticipated Available Unexpected increase in consumer demand 7/08/2024 tadalafil Tablet, film coated 10 mg Current Unavailable Manufacturing 7/08/2024 tadalafil Tablet, film coated 20 mg Current Unavailable Manufacturing 7/08/2024 ephedrine hydrochloride Injection, solution 30 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/08/2024 nebivolol hydrochloride Tablet 5.45 mg Resolved Available Manufacturing 7/08/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Current Limited Availability Manufacturing 7/08/2024 hydrocortisone acetate Enema 10 % w/w Discontinued Unavailable Manufacturing 7/08/2024 gramicidin~framycetin sulfate~dexamethasone Ear Drops .05 mg/mL~5 mg/mL~.5 mg/mL Current Unavailable Manufacturing 7/08/2024 rifampicin Capsule, hard 150 mg Current Unavailable Manufacturing 7/08/2024 eprosartan mesilate Tablet, film coated 735.8 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/08/2024 alprostadil Injection, powder for 40 microgram/mL Current Unavailable Manufacturing 7/08/2024 sildenafil citrate Tablet, film coated 28.09 mg Current Limited Availability Unexpected increase in consumer demand 6/08/2024 ramipril Tablet, uncoated 5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/08/2024 ramipril Tablet, uncoated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 6/08/2024 isoniazid Tablet, uncoated 100 mg Current Unavailable Manufacturing 6/08/2024 prochlorperazine maleate Tablet 5 mg Resolved Available Manufacturing 6/08/2024 pramipexole dihydrochloride monohydrate Tablet .25 mg Resolved Available Manufacturing 6/08/2024 oseltamivir phosphate Oral Liquid, powder for 7.88 mg/mL Current Emergency Supply Only Unexpected increase in consumer demand 6/08/2024 ropivacaine hydrochloride Injection, solution 400 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 6/08/2024 trandolapril Capsule, hard 2 mg Current Limited Availability Manufacturing 6/08/2024 trandolapril Capsule, hard 4 mg Current Limited Availability Manufacturing 6/08/2024 efmoroctocog alfa Injection, powder for 250 IU Current Unavailable Manufacturing 6/08/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 6/08/2024 tadalafil Tablet, film coated 20 mg Current Unavailable Unexpected increase in consumer demand 6/08/2024 latanoprost Eye Drops, solution .05 mg/mL Resolved Available Manufacturing 6/08/2024 bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrate Injection, solution 2.64 mg/mL~4.5 microgram/mL Current Limited Availability Manufacturing 6/08/2024 nebivolol hydrochloride Tablet 5.45 mg Resolved Available Manufacturing 6/08/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Manufacturing 6/08/2024 iopromide Injection, solution 768.86 mg/mL Current Unavailable Unexpected increase in consumer demand 6/08/2024 timolol maleate Eye Drops, solution 6.84 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 6/08/2024 mianserin hydrochloride Tablet, film coated 20 mg Current Limited Availability Manufacturing 6/08/2024 estradiol~norethisterone acetate Drug delivery system, transdermal .512 mg~4.8 mg Current Unavailable Manufacturing 6/08/2024 alprostadil Injection, powder for 20 microgram/mL Current Unavailable Manufacturing 6/08/2024 metformin hydrochloride Tablet, film coated 500 mg Current Unavailable Manufacturing 6/08/2024 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 6/08/2024 zoledronic acid monohydrate Injection, solution 5.33 mg Resolved Available Manufacturing 5/08/2024 olanzapine pamoate monohydrate Injection, powder for 931 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 5/08/2024 olanzapine pamoate monohydrate Injection, powder for 690 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 5/08/2024 olanzapine pamoate monohydrate Injection, powder for 483 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 5/08/2024 fentanyl Drug delivery system, transdermal 5.1 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 5/08/2024 fentanyl Drug delivery system, transdermal 2.55 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 5/08/2024 mirtazapine Tablet, film coated 45 mg Anticipated Available Manufacturing 5/08/2024 timolol maleate~dorzolamide hydrochloride Eye Drops, solution 6.83 mg/mL~22.26 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 5/08/2024 pramipexole dihydrochloride monohydrate Tablet 1 mg Resolved Available Manufacturing 5/08/2024 pramipexole dihydrochloride monohydrate Tablet .125 mg Resolved Available Manufacturing 5/08/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Current Limited Availability Manufacturing 5/08/2024 rosuvastatin calcium~ezetimibe Tablet~Tablet, film coated 10.396 mg~10 mg Current Limited Availability Manufacturing 5/08/2024 temozolomide Capsule, hard 5 mg Current Unavailable Manufacturing 5/08/2024 rosuvastatin calcium Tablet, film coated 10.42 mg Resolved Available Manufacturing 5/08/2024 cefuroxime axetil Tablet, film coated 300.715 mg Current Limited Availability Unexpected increase in consumer demand 5/08/2024 mupirocin Ointment 20 mg/g Resolved Available Manufacturing 5/08/2024 alfentanil hydrochloride Injection, solution 1.09 mg Resolved Available Manufacturing 5/08/2024 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 5/08/2024 montelukast sodium Tablet, film coated 10.4 mg Current Limited Availability Unexpected increase in consumer demand 5/08/2024 mycophenolate mofetil Injection, powder for 500 mg Current Unavailable Manufacturing 5/08/2024 spironolactone Tablet, uncoated 100 mg Anticipated Available Manufacturing 5/08/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 5/08/2024 indometacin Capsule, hard 25 mg Current Limited Availability Manufacturing 5/08/2024 temozolomide Capsule, hard 5 mg Anticipated Available Manufacturing 5/08/2024 raltitrexed Injection, powder for 2 mg Resolved Available Unexpected increase in consumer demand 5/08/2024 captopril Tablet, uncoated 25 mg Current Unavailable Manufacturing 5/08/2024 captopril Tablet, uncoated 50 mg Current Unavailable Manufacturing 5/08/2024 dorzolamide hydrochloride~timolol maleate Eye Drops, solution 22.26 mg/mL~6.83 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 5/08/2024 flecainide acetate Tablet, uncoated 100 mg Current Limited Availability Manufacturing 5/08/2024 midazolam Injection, solution 5 mg/mL Current Unavailable Manufacturing 5/08/2024 - 2024.08.06
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated prazosin hydrochloride Tablet, uncoated 5.476 mg Resolved Available Unexpected increase in consumer demand 2/08/2024 fluorouracil Cream 50 mg/g Current Limited Availability Manufacturing 2/08/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 2/08/2024 ondansetron hydrochloride dihydrate Tablet, film coated 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 2/08/2024 emtricitabine~tenofovir disoproxil fumarate Tablet, film coated 200 mg~300 mg Current Limited Availability Commercial Changes / Commercial viability 2/08/2024 dasatinib Tablet, film coated 100 mg Anticipated Available Manufacturing 2/08/2024 atomoxetine hydrochloride Capsule, hard 45.5 mg Current Limited Availability Manufacturing 2/08/2024 risperidone Oral Liquid, solution 1 mg/mL Current Unavailable Manufacturing 2/08/2024 olmesartan medoxomil~hydrochlorothiazide~amlodipine besilate Tablet, film coated 40 mg~25 mg~6.95 mg Current Unavailable Manufacturing 2/08/2024 mycophenolate sodium Tablet, enteric coated 384.7 mg Anticipated Available Manufacturing 2/08/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Current Unavailable Manufacturing 2/08/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~13.88 mg Current Limited Availability Manufacturing 2/08/2024 erythromycin ethyl succinate Oral Liquid, powder for 468 mg Anticipated Available Unexpected increase in consumer demand 2/08/2024 heparin sodium Injection, solution 10 IU/mL Anticipated Available Manufacturing 2/08/2024 sodium lactate~icodextrin~magnesium chloride hexahydrate~calcium chloride dihydrate~sodium chloride Solution, dialysis 4.5 g/L~75 g/L~51 mg/L~257 mg/L~5.4 g/L Current Limited Availability Manufacturing 2/08/2024 medroxyprogesterone acetate Injection, suspension 150 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 1/08/2024 gliclazide Tablet, modified release 30 mg Current Unavailable Manufacturing 1/08/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 1/08/2024 enalapril maleate Tablet 10 mg Current Unavailable Manufacturing 1/08/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Unavailable Manufacturing 1/08/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 1/08/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 1/08/2024 tranexamic acid Injection, solution 1000 mg Anticipated Available Commercial Changes / Commercial viability 1/08/2024 chromium(51Cr) edetate Injection, solution 8 MBq/mL Current Unavailable Manufacturing 1/08/2024 desvenlafaxine benzoate Tablet, modified release 73.16 mg Resolved Available Manufacturing 1/08/2024 cefepime hydrochloride monohydrate Injection, powder for 2378.5 mg Current Limited Availability Manufacturing 1/08/2024 ribavirin Tablet, film coated 200 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 1/08/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 1/08/2024 imatinib mesilate Capsule, hard 119.47 mg Anticipated Available Manufacturing 1/08/2024 dosulepin (dothiepin) hydrochloride Capsule, hard 25 mg Anticipated Available Manufacturing 1/08/2024 gliclazide Tablet, modified release 30 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 1/08/2024 cinacalcet hydrochloride Tablet, film coated 66 mg Current Unavailable Manufacturing 1/08/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~82.725 mg Current Unavailable Manufacturing 1/08/2024 modafinil Tablet, uncoated 100 mg Current Limited Availability Manufacturing 1/08/2024 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 1/08/2024 lurasidone hydrochloride Tablet, film coated 40 mg Current Unavailable Manufacturing 1/08/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.8 mg Current Limited Availability Manufacturing 1/08/2024 larotrectinib sulfate Oral Liquid, solution 24.6 mg/mL Resolved Available Manufacturing 1/08/2024 heparin sodium Injection, solution 1000 IU/mL Current Unavailable Manufacturing 1/08/2024 doxycycline monohydrate Tablet, uncoated 104.1 mg Current Limited Availability Manufacturing 1/08/2024 sodium pertechnetate(99mTc) Injection, solution 20 GBq Current Limited Availability Manufacturing 1/08/2024 sodium pertechnetate(99mTc) Injection 370 GBq Current Limited Availability Manufacturing 1/08/2024 baclofen Tablet, uncoated 10 mg Resolved Available Manufacturing 1/08/2024 ethosuximide Capsule, soft 250 mg Current Unavailable Manufacturing 1/08/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Anticipated Available Manufacturing 31/07/2024 griseofulvin Tablet, uncoated 125 mg Current Unavailable Manufacturing 31/07/2024 olanzapine Tablet, uncoated 7.5 mg Resolved Available Manufacturing 31/07/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Current Limited Availability Manufacturing 31/07/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~20.791 mg Resolved Available Manufacturing 31/07/2024 entecavir Tablet, film coated 1 mg Current Unavailable Manufacturing 31/07/2024 oxycodone hydrochloride Capsule, hard 10 mg Current Unavailable Commercial Changes / Commercial viability 31/07/2024 rosuvastatin calcium Tablet, film coated 5.21 mg Current Limited Availability Manufacturing 31/07/2024 emtricitabine~tenofovir disoproxil maleate Tablet, film coated 200 mg~300 mg Current Limited Availability Manufacturing 31/07/2024 mercaptopurine monohydrate Tablet 50 mg Current Limited Availability Manufacturing 31/07/2024 ketorolac trometamol Injection, solution 30 mg/mL Current Unavailable Manufacturing 31/07/2024 Avalglucosidase alfa Injection, powder for 100 mg Resolved Available Manufacturing 31/07/2024 lanreotide acetate Injection, solution 133.33 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 31/07/2024 ezetimibe~rosuvastatin calcium Tablet 10 mg~10.4 mg Current Limited Availability Manufacturing 31/07/2024 rifampicin Capsule, hard 150 mg Current Unavailable Manufacturing 31/07/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 31/07/2024 varenicline tartrate~varenicline tartrate Tablet, film coated .85 mg~1.71 mg Current Unavailable Manufacturing 30/07/2024 varenicline tartrate Tablet, film coated 1.71 mg Current Unavailable Manufacturing 30/07/2024 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 30/07/2024 albendazole Tablet, chewable 400 mg Resolved Available Commercial Changes / Commercial viability 30/07/2024 salbutamol sulfate Inhalation, conventional 3 mg Current Unavailable Manufacturing 29/07/2024 sodium pertechnetate(99mTc) Injection, solution 18.5 GBq Current Unavailable Manufacturing 29/07/2024 paliperidone Tablet, modified release 6 mg Resolved Available Manufacturing 29/07/2024 Somatropin Injection, powder for 12 mg/mL Resolved Available Unexpected increase in consumer demand 29/07/2024 donepezil hydrochloride Tablet, film coated 5 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 29/07/2024 omeprazole Capsule 20 mg Current Limited Availability Manufacturing 29/07/2024 drospirenone~ethinylestradiol Tablet 3 mg~30 microgram Resolved Available Manufacturing 29/07/2024 trandolapril Capsule, hard .5 mg Current Limited Availability Manufacturing 29/07/2024 trandolapril Capsule, hard 1 mg Anticipated Available Manufacturing 29/07/2024 Omalizumab Injection, solution 150 mg Current Emergency Supply Only Manufacturing 29/07/2024 quetiapine fumarate Tablet, film coated 345.36 mg Anticipated Available Manufacturing 29/07/2024 adefovir dipivoxil Tablet 10 mg Current Unavailable Unexpected increase in consumer demand 29/07/2024 temozolomide Capsule, hard 180 mg Anticipated Available Manufacturing 29/07/2024 rosuvastatin calcium Tablet, film coated 41.68 mg Current Unavailable Commercial Changes / Commercial viability 29/07/2024 potassium clavulanate~amoxicillin trihydrate Tablet, film coated 148.875 mg~1006.25 mg Current Unavailable Manufacturing 29/07/2024 mesalazine Tablet, enteric coated 800 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 29/07/2024 tadalafil Tablet 5 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 29/07/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Manufacturing 29/07/2024 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 29/07/2024 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 29/07/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~41.363 mg Current Unavailable Manufacturing 29/07/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 41.363 mg~10 mg Current Unavailable Manufacturing 29/07/2024 dimethyl fumarate Capsule, enteric 240 mg Resolved Available Transport / Logistic issues / Storage capacity issues 29/07/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 29/07/2024 nebivolol hydrochloride Tablet 5.45 mg Current Unavailable Manufacturing 29/07/2024 mesalazine Tablet, enteric coated 1.6 g Anticipated Available Transport / Logistic issues / Storage capacity issues 29/07/2024 lacosamide Tablet, film coated 50 mg Current Unavailable Manufacturing 29/07/2024 mycophenolate mofetil Suspension 200 mg/mL Current Limited Availability Manufacturing 29/07/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 109 mg Current Unavailable Manufacturing 29/07/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 54.5 mg Current Unavailable Manufacturing 29/07/2024 sitagliptin hydrochloride monohydrate Tablet, film coated 27.25 mg Current Unavailable Manufacturing 29/07/2024 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.6 mg Current Unavailable Manufacturing 29/07/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 2.7 mg~.62 mg Current Unavailable Manufacturing 29/07/2024 baclofen Tablet 10 mg Resolved Available Manufacturing 29/07/2024 - 2024.07.29
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated isosorbide dinitrate Tablet, uncoated 5 mg Anticipated Available Manufacturing 26/07/2024 fluorouracil Cream 50 mg/g Current Limited Availability Manufacturing 26/07/2024 gabapentin Tablet, film coated 800 mg Current Unavailable Manufacturing 26/07/2024 codeine phosphate hemihydrate~ibuprofen Tablet, film coated 12.8 mg~200 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 26/07/2024 donepezil hydrochloride Tablet, film coated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 26/07/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 26/07/2024 montelukast sodium Tablet, chewable 4.16 mg Resolved Available Manufacturing 26/07/2024 betamethasone acetate~betamethasone sodium phosphate Injection, suspension 3 mg/mL~3.9 mg/mL Resolved Available Product recall 26/07/2024 gallium (67Ga) citrate Injection, solution 74 MBq/mL Current Unavailable Manufacturing 26/07/2024 zolmitriptan Tablet, film coated 2.5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 26/07/2024 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 26/07/2024 simvastatin Tablet, film coated 20 mg Anticipated Available Manufacturing 26/07/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Current Unavailable Manufacturing 26/07/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Current Limited Availability Commercial Changes / Commercial viability 26/07/2024 tadalafil Tablet, film coated 5 mg Resolved Available Transport / Logistic issues / Storage capacity issues 26/07/2024 nebivolol hydrochloride Tablet 10.9 mg Anticipated Available Manufacturing 26/07/2024 dasatinib Tablet, film coated 50 mg Current Unavailable Manufacturing 26/07/2024 dasatinib Tablet, film coated 70 mg Anticipated Available Commercial Changes / Commercial viability 26/07/2024 atomoxetine hydrochloride Capsule, hard 45.5 mg Current Limited Availability Manufacturing 26/07/2024 cinacalcet hydrochloride Tablet, film coated 99 mg Current Unavailable Manufacturing 26/07/2024 cinacalcet hydrochloride Tablet, film coated 33 mg Current Limited Availability Manufacturing 26/07/2024 lacosamide Tablet, film coated 150 mg Anticipated Available Manufacturing 26/07/2024 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 26/07/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~82.725 mg Current Unavailable Manufacturing 26/07/2024 lidocaine hydrochloride Injection, solution 400 mg Current Unavailable Manufacturing 26/07/2024 estradiol Drug delivery system, transdermal .39 mg Current Unavailable Manufacturing 26/07/2024 lanreotide acetate Injection, solution 100 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 26/07/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Current Limited Availability Manufacturing 26/07/2024 idarubicin hydrochloride Injection, solution 1 mg/mL Resolved Available Manufacturing 26/07/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Anticipated Available Manufacturing 25/07/2024 glimepiride Tablet, uncoated 3 mg Resolved Available Manufacturing 25/07/2024 anidulafungin Injection, powder for 100 mg Anticipated Available Manufacturing 25/07/2024 gabapentin Tablet, film coated 600 mg Anticipated Available Manufacturing 25/07/2024 prochlorperazine maleate Tablet 5 mg Current Unavailable Manufacturing 25/07/2024 risperidone Tablet, film coated 3 mg Current Unavailable Manufacturing 25/07/2024 risperidone Tablet, film coated 1 mg Current Unavailable Manufacturing 25/07/2024 risperidone Tablet, film coated 2 mg Current Unavailable Manufacturing 25/07/2024 hydrocortisone sodium succinate Injection, powder for 334.25 mg Current Limited Availability Manufacturing 25/07/2024 Choriogonadotropin alfa Injection, solution 250 microgram Current Limited Availability Unexpected increase in consumer demand 25/07/2024 sildenafil citrate Tablet, film coated 28.1 mg Current Unavailable Manufacturing 25/07/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Resolved Available Manufacturing 25/07/2024 duloxetine hydrochloride Capsule, enteric 67.3 mg Resolved Available Manufacturing 25/07/2024 cefepime hydrochloride monohydrate Injection, powder for 2378.5 mg Anticipated Available Manufacturing 25/07/2024 olmesartan medoxomil Tablet 40 mg Current Limited Availability Manufacturing 25/07/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 25/07/2024 latanoprost Eye Drops, solution .05 mg/mL Current Unavailable Manufacturing 25/07/2024 lacosamide Tablet, film coated 100 mg Anticipated Available Manufacturing 25/07/2024 risperidone Tablet, film coated 3 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 25/07/2024 risperidone Tablet, film coated 4 mg Current Unavailable Manufacturing 25/07/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~10.341 mg Current Limited Availability Manufacturing 25/07/2024 aciclovir Injection, solution 25 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 25/07/2024 gliclazide Tablet, uncoated 80 mg Anticipated Available Unexpected increase in consumer demand 25/07/2024 larotrectinib sulfate Oral Liquid, solution 24.6 mg/mL Anticipated Available Manufacturing 25/07/2024 azithromycin dihydrate Tablet, film coated 628.93 mg Anticipated Available Manufacturing 25/07/2024 zoledronic acid monohydrate Injection, solution 5.33 mg Resolved Available Manufacturing 24/07/2024 ondansetron hydrochloride dihydrate Injection, solution 5 mg Current Limited Availability Manufacturing 24/07/2024 ondansetron hydrochloride dihydrate Injection, solution 10 mg Current Unavailable Manufacturing 24/07/2024 hydrocortisone sodium succinate Injection, powder for 134 mg Current Limited Availability Manufacturing 24/07/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 24/07/2024 bosentan monohydrate Tablet, film coated 129.08 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/07/2024 cinacalcet hydrochloride Tablet 33.064 mg Current Unavailable Manufacturing 24/07/2024 cinacalcet hydrochloride Tablet 66.127 mg Current Unavailable Manufacturing 24/07/2024 alfentanil hydrochloride Injection, solution 1.09 mg Current Limited Availability Manufacturing 24/07/2024 estradiol Drug delivery system, transdermal .78 mg Current Unavailable Manufacturing 24/07/2024 varenicline tartrate~varenicline tartrate Tablet, film coated .855 mg~1.71 mg Resolved Available Manufacturing 24/07/2024 rifampicin Capsule, hard 150 mg Current Unavailable Manufacturing 24/07/2024 fluoxetine hydrochloride Capsule, hard 22.36 mg Current Limited Availability Manufacturing 24/07/2024 doxycycline monohydrate Tablet, uncoated 104.1 mg Current Limited Availability Manufacturing 24/07/2024 tobramycin Inhalation, conventional 60 mg/mL Current Unavailable Manufacturing 24/07/2024 zolpidem tartrate Tablet, film coated 10 mg Current Limited Availability Manufacturing 23/07/2024 medroxyprogesterone acetate Injection, suspension 150 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 23/07/2024 bupivacaine hydrochloride~adrenaline (epinephrine) acid tartrate Injection, solution 2.5 mg/mL~4.5 microgram/mL Resolved Available Manufacturing 23/07/2024 perindopril erbumine Tablet 8 mg Current Unavailable Manufacturing 23/07/2024 sildenafil citrate Tablet, film coated 28.1 mg Current Unavailable Manufacturing 23/07/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Limited Availability Manufacturing 23/07/2024 ezetimibe~atorvastatin calcium trihydrate Tablet, multilayer 10 mg~10.9 mg Anticipated Available Manufacturing 23/07/2024 vecuronium bromide Injection, powder for 10 mg Resolved Available Manufacturing 23/07/2024 oxycodone hydrochloride Capsule, hard 10 mg Current Unavailable Commercial Changes / Commercial viability 23/07/2024 melphalan hydrochloride Injection, powder for 55.97 mg Resolved Available Manufacturing 23/07/2024 tadalafil Tablet, film coated 5 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 23/07/2024 lurasidone hydrochloride Tablet, film coated 80 mg Current Unavailable Manufacturing 23/07/2024 lurasidone hydrochloride Tablet, film coated 40 mg Current Unavailable Manufacturing 23/07/2024 posaconazole Tablet, modified release 100 mg Resolved Available Manufacturing 23/07/2024 levothyroxine sodium Tablet, uncoated .1 mg Current Unavailable Manufacturing 23/07/2024 medroxyprogesterone acetate Injection, suspension 150 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 23/07/2024 minocycline hydrochloride dihydrate Tablet, film coated 54 mg Resolved Available Manufacturing 23/07/2024 ezetimibe Tablet 10 mg Current Limited Availability Unexpected increase in consumer demand 23/07/2024 framycetin sulfate~dexamethasone~gramicidin Ear Drops 5 mg/mL~.5 mg/mL~.05 mg/mL Current Unavailable Manufacturing 22/07/2024 sodium pyrophosphate Injection, powder for 30 mg Resolved Available Manufacturing 22/07/2024 vecuronium bromide Injection, powder for 10 mg Resolved Available Unexpected increase in consumer demand 22/07/2024 donepezil hydrochloride Tablet, film coated 10 mg Current Limited Availability Manufacturing 22/07/2024 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Unavailable Manufacturing 22/07/2024 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Manufacturing 22/07/2024 pramipexole dihydrochloride monohydrate Tablet .125 mg Current Limited Availability Manufacturing 22/07/2024 latanoprost~timolol maleate Eye Drops, solution 50 microgram/mL~6.83 mg/mL Current Unavailable Unexpected increase in consumer demand 22/07/2024 cinacalcet hydrochloride Tablet 99.191 mg Current Unavailable Manufacturing 22/07/2024 tadalafil Tablet, film coated 20 mg Resolved Available Unexpected increase in consumer demand 22/07/2024 tadalafil Tablet, film coated 20 mg Current Unavailable Unexpected increase in consumer demand 22/07/2024 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 20.681 mg~10 mg Current Unavailable Manufacturing 22/07/2024 morphine sulfate pentahydrate Capsule, modified release 30 mg Discontinued Unavailable Commercial Changes / Commercial viability 22/07/2024